Objective: Thyroid pathologies and non-medullary thyroid cancer often accompany primary hyperparathyroidism (PHPT). The purpose of this study was to examine the association between thyroid diseases, especially micropapillary thyroid cancer, with PHPT.
INTRODUCTION
Primary hyperparathyroidism (PHPT) is a disease characterized by an increase in serum parathyroid hormone levels due to parathyroid adenoma, hyperplasia or rarely cancer. Its treatment requires surgical resection of the related parathyroid gland or glands. Thyroid cancer and benign thyroid pathologies usually accompany PHPT. Therefore, in order to avoid re-operations and to provide appropriate surgical treatment, patients who will undergo surgery for PHPT should be thoroughly evaluated in the preoperative period for the presence of possible accompanying thyroid diseases.
In this study, accompanying thyroid disorders in patients operated for PHPT between June 2009 and March 2013 were analyzed.
MATERIAL AND METHODS
Medical records of 46 patients who underwent surgery at our center between June 2009 and March 2013 for PHPT were retrospectively analyzed. Data regarding age, gender, preoperative calcium, parathyroid hormone and phosphorus levels, and the histopathology results of removed parathyroid and thyroid tissues were evaluated. All of the patients had a preoperative diagnosis of PHPT, and none had a previous history of radiation to the head and neck radiation.
Concomitant thyroid pathologies were identified either on physical examination, neck ultrasonography, scintigraphy or during surgery.
RESULTS
Forty-six patients underwent surgery due to primary hyperparathyroidism, 39 of them were females and seven were males. The mean age was 52.8 (25-76) years. Simultaneous thyroidectomy was performed in 35 patients (76.1%) due to an accompanying thyroid disorder. Papillary microcarcinoma was detected in 5 of 35 thyroidectomy patients (10.9%). The mean diameter of papillary microcarcinoma was 0.42±0.2 cm. In two of these patients (40%) more than one tumor foci were identified ( Table 1 ). The following benign thyroid diseases were detected in the remaining 30 (65.2%) cases: lymphocytic thyroiditis in three patients, Hashimoto's thyroiditis in one patient, follicular adenoma (two with Hurtle cell) in three patients, and nodular colloidal goiter in the remaining 23 patients ( Table 2) . A statistically significant relationship was not detected between preoperative serum calcium or parathyroid hormone levels and thyroid papillary micro-carcinoma, whereas preoperative serum phosphate levels were significantly higher (p=0.013) in the group with thyroid papillary micro-carcinoma (Table 3) .
DISCUSSION
Thyroid gland pathologies are frequent, and 11% of the world population has thyroid gland pathology (1). In our country, there are approximately 5 million patients with goiter (2). Thyroid malignancy can be detected in 5% of surgically treated thyroid nodules (3). In a study from Turkey, thyroid malignancies were identified in 8.9% of patients who had thyroid diseases. In the same study, the rate of papillary thyroid cancer was reported as 6.6% (4).
In our study, the rate of thyroid pathologies accompanying PHPT was identified as high as 65.2%. In the literature, the rate of benign thyroid diseases concomitant with PHPT ranges from 17 to 66% (5).
Although the incidence of papillary thyroid micro-carcinoma varies according to geographic regions, there are no studies on the prevalence of thyroid papillary micro-carcinoma within the normal population in our country. In our study, the rate of thyroid papillary micro-carcinoma concomitant with PHPT was identified to be high, 10.9%.
Ogburn et al. (6) have reported the presence of papillary thyroid cancer concomitant with primary hyperparathyroidism for the first time in 1956. In several studies, the frequency of this association has been reported as 1.3-17.6% (5, (7) (8) (9) (10) (11) (12) . To the best of our knowledge, the highest rate of papillary thyroid cancer accompanying PHPT was reported from Van Yüzüncü Yıl University (Table 4) . To the best of our knowledge the rate detected in our study, 10.9%, is the third highest rate reported in the literature. We believe that more frequent diagnosis of thyroid diseases in some endemic regions may contribute to this high rate. The city of Malatya is among endemic goiter regions in our country. In a study conducted in 2003 by the Ministry of Health, Division of Family and Child Health, and UNICEF Turkey, the ultrasonographic prevalence of goiter was found to be 45% (13). In our study, none of the patients with papillary thyroid microcarcinoma had distant metastasis. However, metastatic cases have been reported in the literature (11) . There are also studies that reported mortality due to metastasis (14, 15) . Additionally, 2 (40%) patients were found to have multicentric disease in our study ( Table 1 ). The rate of multicentricity in papillary thyroid microcarcinoma ranges from 9.5 to 24.9% (16) .
There is no agreement on the treatment of incidental thyroid papillary micro-carcinoma. Some studies suggest only followup of these lesions due to their indolent course in general, while some studies advocate a more aggressive treatment (bilateral total thyroidectomy) due to the possibility of their being multifocal and leading to mortality by metastasis (15, 17) .
In our study, there were no statistically significant differences in terms of preoperative serum calcium and parathyroid hormone levels between patients with thyroid papillary microcarcinoma and those either without an accompanying thyroid pathology or with benign thyroid pathology. However, serum phosphate levels were detected to be significantly higher (p=0.013). In a study conducted with PHPT patients with or without concomitant thyroid pathologies, it was reported that preoperative serum calcium levels were significantly higher in patients with thyroid diseases; however, a statistically significant difference in serum parathyroid hormone levels was not detected. In the same study, serum phosphate levels were significantly higher in patients with concomitant thyroid pathologies (7) . Therefore, we believe that high phosphate levels increase the probability of detection of thyroid papillary micro-carcinoma in patients with concomitant thyroid pathologies. Nevertheless, we believe that larger series are required to make a definitive statement.
CONCLUSION
Thyroid diseases and thyroid papillary micro-carcinoma accompany PHPT at a higher rate than the normal population, especially in regions with endemic goiter. Therefore, we believe that patients who are scheduled for an operation due to PHPT in these regions should be thoroughly evaluated in the preoperative period for the presence of concomitant malignant thyroid pathologies. In addition, in patients who are prepared to undergo parathyroidectomy for PHPT, it should be kept in mind that the risk of thyroid papillary microcarcinoma may have increased if their preoperative serum phosphate values are high.
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